HCA Healthcare (HCA) Stock Sinks As Q3 Results Expose Payer Mix Strain

HCA Healthcare just reported Q3 2026 numbers and the stock is feeling it. The shares closed down 3.3% on the day, even though adjusted diluted earnings per share landed in the mid 7 dollar range and net profit margins over the last year held near 8.6%.

The main story is the tension between today’s price move and the longer view on valuation and balance sheet strain. A trailing P/E of 14.4x looks lower than both peers and the wider healthcare group, yet investors are still weighing that against high debt and a capital structure marked by negative shareholders’ equity.

Love HCA Healthcare’s mid 7 dollar EPS and 8.6% net margin but worried about the heavy leverage and negative equity? Check out the list of solid balance sheet and fundamentals stocks (24 results) for stocks that pair earnings power with sturdier balance sheets.

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): US$19,849 million vs. US$19,161 million (up 3.6%)
• Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): US$1,579 million vs. US$1,643 million (down 3.9%)
• Basic EPS (Q3 2026 vs. Q3 2025): US$7.27 vs. US$7.05 (up 3.0%)
• Net Profit Margin (Trailing 12 Months vs. Prior Year): 8.6% vs. 8.5% (slight improvement)

Insured volumes rose even as more patients lost coverage. Ask Charlie what HCA Healthcare’s exchange-to-uninsured shift really means.

HCA Healthcare: Capacity Play Meets Cost Discipline

Bulls argue HCA Healthcare’s build out and efficiency push can keep the growth story intact even with payer noise in the background.

"HCA Healthcare’s capital program, including 2026 capex of US$5.0 to US$5.5b, more than US$7b of approved projects over the next three years, and plans for 1,000 to 1,200 additional inpatient beds and 250 to 300 new outpatient facilities, is set to expand capacity and support future revenue growth."

Q3 volumes rose again, with equivalent admissions up 3.0% and ER visits up 5.1%, which shows existing assets are absorbing demand. Cost per equivalent admission staying essentially flat year on year reinforces that the resiliency program is doing real work. Together, these data points support the idea that HCA can put that US$7b project pipeline to use without margin erosion so far, even as payer mix moves against it.

HCA Healthcare: Payer Mix Risk Hits The P&L

The bear case focuses on policy and payer mix turning volume growth into much thinner earnings progress.

"Persistent uncertainty and potential negative impacts of the evolving federal policy environment remain a live issue, as the expiration of enhanced exchange tax credits has already led to a large shift from insured to uninsured patients and a sizeable EBITDA headwind."

That warning is playing out in the current numbers. Management quantified the exchange to uninsured migration as roughly a US$400m adjusted EBITDA drag in Q3 alone, with uninsured admissions rising to about 10.5% from 8.5%. Full year 2026 exchange related impact is now expected at or above the high end of earlier estimates. Early 2027 commentary also points to US$550m to US$650m less Medicaid supplemental benefit, which keeps this risk very much live despite solid insured volumes.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Hunt For Mispriced Earnings Power

HCA Healthcare reports a quarter where strong patient volumes meet shifting policy signals. The real opportunity is studying stocks that might not yet reflect changes in their earnings power.

• Company 1 - 31% below our estimate - builds dense compute racks that prompt data centers to expand power capacity plans.
• Company 2 - 32% below our estimate - tightens an operations playbook targeting higher-margin aftermarket service and complex valve projects.
• Company 3 - 34% below our estimate - supplies AI infrastructure clusters that large model developers use across multiple cloud environments.

Those are three of them. See every one of the 29 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com